Did you know that there are about 14 million people in the United States who struggle with a major depressive disorder at some point in their lives? Shocking, right? Well, even more incredible is that 30% of those people suffer from treatment-resistant depression: they did not respond to two or more previous treatment options, or have had a relapse of symptoms. However, over the past few decades there have been a multitude of new studies and developments for treating severe or treatment-resistant depressive symptoms. For example, a nasal spray called esketamine (branded under the name Spravato) has recently received FDA approval after going through multiple clinical trials.

For those of you who are not familiar with esketamine, it is the enantiomer, or chemical cousin, of ketamine, which is arguably more potent. It was developed to work in combination with oral antidepressants, and also, to treat patients who have not responded to at least two other forms of treatment. The spray works by acting on the receptors in the brain, relieving depressive symptoms rapidly and effectively. We believe that this the many other new developments in depression medication have the potential to save thousands of lives.

What about abuse? Well, like ketamine, the nasal spray is not given as a take home treatment and is required to be administered at a doctor’s office. Because of the high regulation of amount and circumstances of use, the chance of addiction is significantly reduced. When you choose Spravato, you are required to wait in the doctor’s office for two hours post-administration to assess any side effects. In addition, you must sign a statement saying you will not operate heavy machinery or motor vehicles for a whole 24-hours after treatment. These regulations are for the patient’s protection, and besides the time-consuming nature of administration, we believe this drug could save millions of lives.

To learn more about esketamine nasal spray visit the link below: https://www.self.com/story/esketamine-for-depression

For those who don’t qualify for Esketamine administration, or who cannot afford the cost of treatment, ketamine—the drug that inspired the development of Spravato—is still a great and viable option for patients with treatment-resistant depression. Ketamine infusions are required to be administered under medical supervision, so the chance of abuse or becoming addicted is minute. Also, being one of the most successful ketamine clinics in the Boston, MA and West Hartford, CT areas, we have personally seen how rapid and effectively the ketamine infusions work to relieve our patients’ depressive symptoms. Even better, the positive results are known to be lasting. With a 70% success rate, we know and love seeing how ketamine turns around the lives of so many who seem lost.

There is hope. You must choose to search for it and accept it.

ketamine for depression

Contact Ketamine Greater Boston & Ketamine West Hartford

Ketamine Greater Boston and Ketamine West Hartford are two of the country’s leading ketamine clinics. We are also proud to be one of very few ketamine clinics to offer Spravato (esketamine). Contact us today to find out if you are a candidate, which treatment is right for you, and how to get started traveling your path towards hope, health and happiness.